News
Tariffs will likely cost Deerfield-based Baxter International $60 million to $70 million this year, the company’s chief financial officer said in an earnings call Thursday.
The Trump administration has not yet imposed tariffs on pharmaceuticals, but is now investigating how imports of ...
With a market cap of $15.6 billion, Baxter International Inc. (BAX) is a global healthcare company that specializes in ...
Today marks a big day for a medical equipment facility in Marion, N.C. Baxter International has been unable to produce its products for nearly two months. In the days following the storm, Baxter ...
Baxter International, a prominent healthcare and pharmaceutical manufacturer, reports that President Trump's tariffs will likely cost the company $60 million to $70 million this year. Baxter makes a ...
Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...
| Baxter International Inc. (NYSE: BAX), a renowned leader in pioneering surgical innovation, announces the introduction of ...
October 24, 2024 Baxter expects to restart IV fluids line at hurricane-hit plant within next week Medical device maker Baxter said on Thursday it expects to restart the highest-throughput ...
Baxter will soon deploy more than 200 plans to help mitigate the shortage and deliver fluids across the U.S. The plant aims to be at 100% production capacity at the North Cove plant by the end of ...
Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ETCompany ParticipantsClare Trachtman - Senior Vice President ...
Baxter makes IV fluids, a number of pharmaceuticals and other hospital products. “We are able to mitigate a portion of these impacts,” Grade said. “Currently a majority of Baxter’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results